Leptin reverses nonalcoholic steatohepatitis in patients with severe lipodystrophy (Q46405084)

From Wikidata

Jump to navigation Jump to search

scientific article published in April 2005

edit

Language	Label	Description	Also known as
English	Leptin reverses nonalcoholic steatohepatitis in patients with severe lipodystrophy	scientific article published in April 2005

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

15791619

retrieved

21 December 2017

reference URL

http://europepmc.org/abstract/MED/15791619

title

Leptin reverses nonalcoholic steatohepatitis in patients with severe lipodystrophy (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

15791619

retrieved

21 December 2017

reference URL

http://europepmc.org/abstract/MED/15791619

main subject

steatohepatitis

0 references

author

David E. Kleiner

series ordinal

7

1 reference

stated in

Europe PubMed Central

PubMed publication ID

15791619

retrieved

21 December 2017

reference URL

http://europepmc.org/abstract/MED/15791619

author name string

Edward D Javor

series ordinal

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

15791619

retrieved

21 December 2017

reference URL

http://europepmc.org/abstract/MED/15791619

Marc G Ghany

series ordinal

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

15791619

retrieved

21 December 2017

reference URL

http://europepmc.org/abstract/MED/15791619

Elaine K Cochran

series ordinal

3

1 reference

stated in

Europe PubMed Central

PubMed publication ID

15791619

retrieved

21 December 2017

reference URL

http://europepmc.org/abstract/MED/15791619

Elif Arioglu Oral

series ordinal

4

1 reference

stated in

Europe PubMed Central

PubMed publication ID

15791619

retrieved

21 December 2017

reference URL

http://europepmc.org/abstract/MED/15791619

Alex M DePaoli

series ordinal

5

1 reference

stated in

Europe PubMed Central

PubMed publication ID

15791619

retrieved

21 December 2017

reference URL

http://europepmc.org/abstract/MED/15791619

Ahalya Premkumar

series ordinal

6

1 reference

stated in

Europe PubMed Central

PubMed publication ID

15791619

retrieved

21 December 2017

reference URL

http://europepmc.org/abstract/MED/15791619

Phillip Gorden

series ordinal

8

1 reference

stated in

Europe PubMed Central

PubMed publication ID

15791619

retrieved

21 December 2017

reference URL

http://europepmc.org/abstract/MED/15791619

language of work or name

English

0 references

publication date

1 April 2005

1 reference

stated in

Europe PubMed Central

PubMed publication ID

15791619

retrieved

21 December 2017

reference URL

http://europepmc.org/abstract/MED/15791619

published in

Hepatology

1 reference

stated in

Europe PubMed Central

PubMed publication ID

15791619

retrieved

21 December 2017

reference URL

http://europepmc.org/abstract/MED/15791619

volume

41

1 reference

stated in

Europe PubMed Central

PubMed publication ID

15791619

retrieved

21 December 2017

reference URL

http://europepmc.org/abstract/MED/15791619

issue

4

1 reference

stated in

Europe PubMed Central

PubMed publication ID

15791619

retrieved

21 December 2017

reference URL

http://europepmc.org/abstract/MED/15791619

page(s)

753-760

1 reference

stated in

Europe PubMed Central

PubMed publication ID

15791619

retrieved

21 December 2017

reference URL

http://europepmc.org/abstract/MED/15791619

cites work

Fatty liver hepatitis and cirrhosis in obese patients

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FHEP.20672

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Non-alcoholic steatohepatitis: another disease of affluence

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FHEP.20672

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Nonalcoholic fatty liver disease

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FHEP.20672

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FHEP.20672

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Non-alcoholic steatohepatitis (NASH): where are we now and where are we going?

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FHEP.20672

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Lipotoxic diseases

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FHEP.20672

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Leptin-replacement therapy for lipodystrophy.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FHEP.20672

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Leptin reverses insulin resistance and hepatic steatosis in patients with severe lipodystrophy

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FHEP.20672

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Introduction of fast MR imaging in the assessment of hepatic steatosis

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FHEP.20672

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

A pilot study of pioglitazone treatment for nonalcoholic steatohepatitis

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FHEP.20672

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Changes in body composition in patients with severe lipodystrophy after leptin replacement therapy.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FHEP.20672

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Nonalcoholic fatty liver disease: a feature of the metabolic syndrome

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FHEP.20672

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy of recombinant methionyl human leptin therapy for the extreme insulin resistance of the Rabson-Mendenhall syndrome

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FHEP.20672

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical course of genetic diseases of the insulin receptor (type A and Rabson-Mendenhall syndromes): a 30-year prospective

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FHEP.20672

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical course of the syndrome of autoantibodies to the insulin receptor (type B insulin resistance): a 28-year perspective

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FHEP.20672

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Leptin stimulates fatty-acid oxidation by activating AMP-activated protein kinase

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FHEP.20672

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

PPAR alpha is necessary for the lipopenic action of hyperleptinemia on white adipose and liver tissue

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FHEP.20672

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Rapid transformation of white adipocytes into fat-oxidizing machines

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FHEP.20672

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Mechanisms controlling mitochondrial biogenesis and respiration through the thermogenic coactivator PGC-1

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FHEP.20672

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Impaired mitochondrial activity in the insulin-resistant offspring of patients with type 2 diabetes

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FHEP.20672

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Selective deletion of leptin receptor in neurons leads to obesity

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FHEP.20672

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

The histological course of nonalcoholic fatty liver disease: a longitudinal study of 103 patients with sequential liver biopsies

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FHEP.20672

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Leptin is essential for the hepatic fibrogenic response to chronic liver injury

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FHEP.20672

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Leptin augments inflammatory and profibrogenic responses in the murine liver induced by hepatotoxic chemicals

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FHEP.20672

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

The role of leptin in NAFLD: contender or pretender?

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FHEP.20672

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Leptin, insulin resistance, and liver fibrosis in human nonalcoholic fatty liver disease

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FHEP.20672

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

A pilot study of a thiazolidinedione, troglitazone, in nonalcoholic steatohepatitis

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FHEP.20672

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Pioglitazone reduces hepatic fat content and augments splanchnic glucose uptake in patients with type 2 diabetes

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FHEP.20672

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Improved nonalcoholic steatohepatitis after 48 weeks of treatment with the PPAR-γ ligand rosiglitazone

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FHEP.20672

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Stimulation of adipogenesis in fibroblasts by PPAR gamma 2, a lipid-activated transcription factor

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FHEP.20672

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Troglitazone increases the number of small adipocytes without the change of white adipose tissue mass in obese Zucker rats

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FHEP.20672

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy and safety of troglitazone in the treatment of lipodystrophy syndromes

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FHEP.20672

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Liver peroxisome proliferator-activated receptor gamma contributes to hepatic steatosis, triglyceride clearance, and regulation of body fat mass.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FHEP.20672

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

DOI

10.1002/HEP.20672

1 reference

stated in

Europe PubMed Central

PubMed publication ID

15791619

retrieved

21 December 2017

reference URL

http://europepmc.org/abstract/MED/15791619

PubMed publication ID

15791619

1 reference

stated in

Europe PubMed Central

PubMed publication ID

15791619

retrieved

21 December 2017

reference URL

http://europepmc.org/abstract/MED/15791619

ResearchGate publication ID

7943543

0 references

 

Sitelinks

Wikipedia(0 entries)

edit

Wikibooks(0 entries)

edit

Wikinews(0 entries)

edit

Wikiquote(0 entries)

edit

Wikisource(0 entries)

edit

Wikiversity(0 entries)

edit

Wikivoyage(0 entries)

edit

Wiktionary(0 entries)

edit

Multilingual sites(0 entries)

edit

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46405084&oldid=2109712080"